{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:01:06Z","timestamp":1784840466213,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,23]]},"DOI":"10.7759\/cureus.113247","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:07:01Z","timestamp":1784837221000},"source":"Crossref","is-referenced-by-count":0,"title":["Celecoxib: Not So Harmless?"],"prefix":"10.7759","author":[{"given":"Ousmane","family":"Kaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra","family":"Chahboun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maman","family":"Idi Chazali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houssam","family":"Bkiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brahim","family":"Housni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reval.2017.06.002","article-title":"Toxic epidermal necrolysis: pathophysiology and therapeutic advances (Article in French)","volume":"57","author":"Villani AP","year":"2017","unstructured":"Villani AP, Vocanson M, Laoubi L, Jullien D, B\u00e9rard F, Nicolas JF, Bensaid B. Toxic epidermal necrolysis: pathophysiology and therapeutic advances (Article in French). Rev Fr Allergol. 2017, 57:418-25. 10.1016\/j.reval.2017.06.002","journal-title":"Rev Fr Allergol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany B","year":"1996","unstructured":"Rzany B, Mockenhaupt M, Baur S, et al.. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. J Clin Epidemiol. 1996, 49:769-73. 10.1016\/0895-4356(96)00035-2","journal-title":"J Clin Epidemiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.17179\/excli2023-6809","article-title":"Celecoxib-induced acute generalized exanthematous pustulosis: uncommon and under-recognized side effect","volume":"23","author":"Abdul Khader AH","year":"2024","unstructured":"Abdul Khader AH, Singh M. Celecoxib-induced acute generalized exanthematous pustulosis: uncommon and under-recognized side effect. EXCLI J. 2024, 23:108-13. 10.17179\/excli2023-6809","journal-title":"EXCLI J"},{"key":"ref4","unstructured":"Celecoxib. mechanism of action. (2013). https:\/\/www.vidal.fr\/medicaments\/substances\/celecoxib-18930.html."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000078588","article-title":"Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far","volume":"209","author":"Goeschke B","year":"2004","unstructured":"Goeschke B, Braathen LR. Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far. Dermatology. 2004, 209:53-6. 10.1159\/000078588","journal-title":"Dermatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0793-7","article-title":"Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)","volume":"13","author":"Ingen-Housz-Oro S","year":"2018","unstructured":"Ingen-Housz-Oro S, Duong TA, Bensaid B, et al.. Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins). Orphanet J Rare Dis. 2018, 13:56. 10.1186\/s13023-018-0793-7","journal-title":"Orphanet J Rare Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong TA","year":"2017","unstructured":"Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet Lond Engl. 2017, 390:1996-2011. 10.1016\/S0140-6736(16)30378-6","journal-title":"Lancet Lond Engl"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.37051\/mir-00149","article-title":"Severe drug eruptions in intensive care (Article in French)","volume":"32","author":"Gaillet A","year":"2023","unstructured":"Gaillet A, Ingen-Housz-Oro S, Chosidow O, de Prost N. Severe drug eruptions in intensive care (Article in French). Med Intensive Reanim. 2023, 32:e00149. 10.37051\/mir-00149","journal-title":"Med Intensive Reanim"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.01.031","article-title":"The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK","volume":"137","author":"Frey N","year":"2017","unstructured":"Frey N, Jossi J, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK. J Invest Dermatol. 2017, 137:1240-7. 10.1016\/j.jid.2017.01.031","journal-title":"J Invest Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0711-x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in association with commonly prescribed drugs in outpatient care other than anti-epileptic drugs and antibiotics: a population-based case-control study","volume":"42","author":"Frey N","year":"2019","unstructured":"Frey N, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. Stevens-Johnson syndrome and toxic epidermal necrolysis in association with commonly prescribed drugs in outpatient care other than anti-epileptic drugs and antibiotics: a population-based case-control study. Drug Saf. 2019, 42:55-66. 10.1007\/s40264-018-0711-x","journal-title":"Drug Saf"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528100-00008","article-title":"Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors","volume":"28","author":"La Grenade L","year":"2005","unstructured":"La Grenade L, Lee L, Weaver J, Bonnel R, Karwoski C, Governale L, Brinker A. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. Drug Saf. 2005, 28:917-24. 10.2165\/00002018-200528100-00008","journal-title":"Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.896867","article-title":"Stevens-Johnson syndrome following non-steroidal anti-inflammatory drugs: a real-world analysis of post-marketing surveillance data","volume":"10","author":"Shao QH","year":"2022","unstructured":"Shao QH, Yin XD, Zeng N, et al.. Stevens-Johnson syndrome following non-steroidal anti-inflammatory drugs: a real-world analysis of post-marketing surveillance data. Front Pediatr. 2022, 10:896867. 10.3389\/fped.2022.896867","journal-title":"Front Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48728","article-title":"A compilation of drug etiologies of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"15","author":"Abulatan IT","year":"2023","unstructured":"Abulatan IT, Ben-David SG, Morales-Colon LA, Beason E, Fakoya AO. A compilation of drug etiologies of Stevens-Johnson syndrome and toxic epidermal necrolysis. Cureus. 2023, 15:e48728. 10.7759\/cureus.48728","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61112-X","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature","volume":"94","author":"Letko E","year":"2005","unstructured":"Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol. 2005, 94:419-36. 10.1016\/S1081-1206(10)61112-X","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt M","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, et al.. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008, 128:35-44. 10.1038\/sj.jid.5701033","journal-title":"J Invest Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri TL","year":"2002","unstructured":"Palmieri TL, Greenhalgh DG, Saffle JR, et al.. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil. 2002, 23:87-96. 10.1097\/00004630-200203000-00004","journal-title":"J Burn Care Rehabil"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fander.2022.09.045","article-title":"Role of plasma exchange in the treatment of toxic epidermal necrolysis (Article in French)","volume":"2","author":"Ragragui Ouasmin H","year":"2022","unstructured":"Ragragui Ouasmin H, Kaouthar S, Saddouk H, Zizi N, Dikhaye S. Role of plasma exchange in the treatment of toxic epidermal necrolysis (Article in French). Ann Dermatol V\u00e9n\u00e9r\u00e9ologie. 2022, 2:A54. 10.1016\/j.fander.2022.09.045","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fander.2023.09.195","article-title":"A case of toxic erythema following enfortumab vedotin treatment managed with plasma exchange (Article in French)","volume":"3","author":"Braud A","year":"2023","unstructured":"Braud A, Bartolomei S, Lenormand C, Lipsker D. A case of toxic erythema following enfortumab vedotin treatment managed with plasma exchange (Article in French). Ann Dermatol V\u00e9n\u00e9r\u00e9ologie. 2023, 3:146-7. 10.1016\/j.fander.2023.09.195","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2002.00409.x","article-title":"Plasma exchange in patients with toxic epidermal necrolysis","volume":"6","author":"Bamichas G","year":"2002","unstructured":"Bamichas G, Natse T, Christidou F, et al.. Plasma exchange in patients with toxic epidermal necrolysis. Ther Apher. 2002, 6:225-8. 10.1046\/j.1526-0968.2002.00409.x","journal-title":"Ther Apher"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53653-5","article-title":"Effectiveness of early treatment with plasma exchange in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Senda A","year":"2024","unstructured":"Senda A, Fushimi K. Effectiveness of early treatment with plasma exchange in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Sci Rep. 2024, 14:2893. 10.1038\/s41598-024-53653-5","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/267336-celecoxib-not-so-harmless","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:07:02Z","timestamp":1784837222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/267336-celecoxib-not-so-harmless"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.113247","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}